A Conotoxin-Derived Peptide Selectively Inhibits PAR-1 Mediated Thrombosis and Neutrophil Extracellular Traps Formation Without Affecting Hemostasis
Thrombosis and Haemostasis · 03.03.2026
DOI: 10.1055/a-2815-5095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 03.03.2026. Verfasst von Aili Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Evolution and Conservation Biology, Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou), Guangzhou, China. Gefördert von: Foundation for Scientific and Technical Project of Nansha, Guangzhou, Key-Area Research and Development Program of Guangdong Province, Guangxi Key Research and Development Program.
Abstract (Originalsprache)
Thrombosis is the key driver for ischemic events including stroke, which is the leading cause of global mortality. However, current antithrombotic therapies carry substantial bleeding risks. Targeting protease-activated receptor-1 (PAR-1), a thrombin-activated receptor central to thrombus growth, represents a promising antithrombotic strategy for safer intervention. Here, we mined the venom gland transcriptome of Conus spp., applied in silico Furin cleavage prediction, synthesized and screened the antiPAR-1 activity of a series of conotoxin-derived peptides. Among them, Cb-26 exhibited the strongest but reversible activity in inhibiting PAR-1 mediated platelet activation and aggregation in vitro. Crucially, Cb-26 inhibited platelet adhesion, neutrophil extracellular traps formation and thrombus growth under shear conditions in whole blood from healthy donors. In murine models, Cb-26 significantly delayed carotid occlusion and reduced cerebral infarct size in photochemical-induced ischemic stroke, without affecting blood coagulation and bleeding time. These results suggest that Cb-26 is a selective and reversible PAR-1 antagonist, and represents a promising antithrombotic candidate without apparent bleeding side effect.
Autor:innen und Institutionen
- Center for Evolution and Conservation Biology, Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou), Guangzhou, China.
- Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
- South China Sea Institute of Oceanology, Chinese Academy of Sciences, Beijing, China.
- Key Laboratory of Bioactive Peptides of Yunnan Province, KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, National Resource Center for Non-Human Primates, Kunming Primate Research Cen…
Förderung
- Foundation for Scientific and Technical Project of Nansha, Guangzhou
- Key-Area Research and Development Program of Guangdong Province
- Guangxi Key Research and Development Program
- PI Project of Southern Marine Science and Engineering Guangdong Laboratory
- Excellent Young Scholars of the Natural Science Foundation of Shandong Province
- Young experts of Taishan Scholars
- Taxonomist project, Chinese Academy of Sciences
- the PI Project of Southern Marine Science and Engineering Guangdong Laboratory
Zitieren
APA
Wang, A., Wang, T., Chen, H., Fang, S., Chen, X., Xu, G., Chen, Z., Liu, M., Shen, C., & Lai, R. (2026). A Conotoxin-Derived Peptide Selectively Inhibits PAR-1 Mediated Thrombosis and Neutrophil Extracellular Traps Formation Without Affecting Hemostasis. Thrombosis and Haemostasis. https://doi.org/10.1055/a-2815-5095
Vancouver
Wang A, Wang T, Chen H, Fang S, Chen X, Xu G, et al. A Conotoxin-Derived Peptide Selectively Inhibits PAR-1 Mediated Thrombosis and Neutrophil Extracellular Traps Formation Without Affecting Hemostasis. Thrombosis and Haemostasis. 2026. doi:10.1055/a-2815-5095
BibTeX
@article{Wang2026,
author = {Wang, Aili and Wang, Tianyu and Chen, Haidong and Fang, Siwen and Chen, Xue and Xu, Gaochi and Chen, Zhiyun and Liu, Ming and Shen, Chuanbin and Lai, Ren},
title = {A Conotoxin-Derived Peptide Selectively Inhibits PAR-1 Mediated Thrombosis and Neutrophil Extracellular Traps Formation Without Affecting Hemostasis},
journal = {Thrombosis and Haemostasis},
year = {2026},
doi = {10.1055/a-2815-5095}
}
EUVIMED